Merck KGaA (XTER:MRK)
€ 155.5 -0.2 (-0.13%) Market Cap: 67.61 Bil Enterprise Value: 75.46 Bil PE Ratio: 23.96 PB Ratio: 2.53 GF Score: 89/100

Q3 2022 Merck KGaA Earnings Call Transcript

Nov 10, 2022 / 01:00PM GMT
Release Date Price: €177.95 (+3.94%)
Operator

Ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on Third Quarter 2022. (Operator Instructions) I'm now handing over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest
MERCK Kommanditgesellschaft auf Aktien - Head of IR

Thank you very much, Sandra. Dear, ladies and gentlemen, a very warm welcome to this Merck Q3 2022 Results Call. My name is Constantin Fest. I'm Head of Investor Relations. I'm delighted to have here today with me Belen Garijo, Group CEO; as well as Marcus Kuhnert, Group CFO. We are also being joined for the Q&A part of this call by Peter Guenter, CEO of Healthcare; as well as Matthias Heinzel, CEO of Life Science; and Kai Beckmann, CEO of Electronics.

The next couple of minutes, we would like to run you through the key slides of this presentation. And right after that, we'll be happy to take all of your questions. Having said that, I'd like to now hand over to Belen to kick off the presentation. Over to you, Belen.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot